The revenue during the period, however, grew with Syngene crossing the ₹1,000-crore mark, touching ₹1,018 crore, up 8 per ...

Dow drops 700 points, Fed Chair Jerome Powell warns of economic risks ...

Unveiled during the BioWave event at C-CAMP in Bangalore, the report presents a deep dive into India’s biotech funding landscape from 2020 to 2024. The report reveals that India’s biotech ...

Earlier this week, the congressionally-mandated National Security Commission on Emerging Biotechnology released its major report, titled “Charting the Future of Biotechnology.” The bipartisan ...

Or, maybe, it's just a grey wolf with a few tweaks. American biotech company Colossal Biosciences made a surprise announcement Monday, claiming it had brought the dire wolf back from the dead ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

America must invest at least $15 billion over the next five years to support its domestic biotechnology sector if it doesn’t want to lose to China, warns a national security commission made up ...

DNA sequencing shares slide amid 'headwinds' from Trump's NIH funding cuts “We believe we are on pace to achieve the financial goals we set earlier this year,” CEO Christian Henry said in a ...

In this edition of the biotech bi-weekly, read about the launch of a next-generation PCR kit, the development of a comprehensive functional genomics platform and the unveiling of a cryo-transmission ...

The U.S.-based biotechnology company is also known for its ambitious goal of bringing back the extinct woolly mammoth by 2028. This dire wolf pup is among the first of its species born in around ...